DHT, the androgen that finasteride and dutasteride lower, enlarges beard follicles and shrinks balding scalp follicles, often in the same man at the same time. The hormone in his blood is the same at both sites, so the difference lies in the follicles themselves.
The short answer: Beard follicles and balding scalp follicles respond to DHT in opposite directions, depending on body site and, on the scalp, genetic susceptibility. In cell culture, androgen makes beard papilla cells send growth signals and balding scalp papilla cells send inhibitory ones (Inui et al. 2002). Finasteride and dutasteride don't appear to thin an established beard: 96.9% of 453 men who stayed on them for at least a year saw no change (Moreno-Arrones et al. 2024).
Why does DHT grow beard hair but cause baldness?
Follicles in different places respond to androgens in different ways. Valerie Randall describes three responses across the body (Randall 2007):
- Follicles on the face, chest and upper pubic area enlarge and make longer, thicker, darker hairs.
- Some, such as the eyelashes, appear unaffected.
- Follicles on specific areas of the scalp shrink in genetically susceptible people.
She calls this "a biological paradox": one hormone stimulates the hair follicle in many areas and inhibits it in another, "often in the same individual".
Both responses depend on androgen signaling. People with complete androgen insensitivity have no functional androgen receptor. They don't develop normal beard, pubic or armpit hair, and male pattern baldness has not been reported in them (as summarized in Hibberts et al. 1998). Men born with 5-alpha-reductase type 2 deficiency make less DHT. Their facial and body hair is "absent or decreased", and "Balding has not been reported" (Imperato-McGinley and Zhu 2002). Randall reads that second group as evidence that DHT itself is needed for the beard, chest and upper pubic diamond (Randall 2007).
Androgens probably act through the dermal papilla, a small cluster of cells at the base of the follicle that controls what kind of hair it makes (Hamada and Randall 2006). In the model Randall's group proposed in 1991, androgens bind receptors in papilla cells. Those cells then change the signals they release to the hair-making cells around them (Randall 2007). Papilla cells from the beard, armpit and frontal scalp carry androgen receptors, while the follicle's epithelial cells "do not have characteristics of the androgen target cells" (Inui et al. 2002).
What do beard and balding papilla cells do differently?
They release different signals when exposed to androgen. Inui and colleagues grew papilla cells from beard, balding scalp and two non-balding scalp sites beside keratinocytes (skin cells), separated by a membrane, with a synthetic androgen (Inui et al. 2002). The androgen raised keratinocyte growth by 41% beside beard cells and cut it by 50% beside balding scalp cells. It had no significant effect beside the non-balding scalp cells.
The balding cells secreted more TGF-beta1, a growth-inhibiting protein, and an antibody that neutralized it reversed the inhibition. Two caveats: the balding cells came from four men, and every cell line had extra androgen receptor added, because cultured papilla cells lose it as they are grown.
On the beard side, one growth signal is IGF-1 (insulin-like growth factor 1). Androgen raised IGF-1 messenger RNA in beard papilla cells and stimulated the growth of outer root sheath cells cultured beside them. An antibody against IGF-1 blocked that effect (Itami et al. 1995). Randall's group found that testosterone at physiological levels increased the release of growth factors from beard papilla cells but not from non-balding scalp cells. Only beard cells responded to those factors (Thornton et al. 1998).
On the balding side, the signals downstream of DHT include DKK-1, a secreted Wnt antagonist. DHT raised DKK-1 in balding papilla cells, and DKK-1 protein was higher in bald than in haired scalp from four patients (Kwack et al. 2008). DHT also raised IL-6, which slowed hair shaft elongation in cultured human follicles (Kwack et al. 2012). And culture medium from balding papilla cells delayed new hair growth when injected into mice (Hamada and Randall 2006).
Some of the differences between sites exist before any androgen is added. Rutberg and colleagues found three genes expressed at higher levels in beard than in back-of-scalp papilla cells, both in culture and in papillae taken straight from follicles (Rutberg et al. 2006). Androgen did not change them in culture, Randall notes (Randall 2007). Her group had already shown that cultured papilla cells keep a phenotype "which depends on the body site from which they were derived" (Randall et al. 1992).
Do beard follicles have more androgen receptors than scalp follicles?
In culture, yes. But so do balding scalp papilla cells, so receptor level alone doesn't explain which way a follicle goes.
Across 12 primary lines of cultured papilla cells, Randall and colleagues found more androgen receptor in cells from beard, scrotal and pubic follicles than from non-balding scalp (Randall et al. 1992). Her group later found more receptor in balding than in non-balding scalp papilla cells: 0.06 against 0.04 fmol per 10,000 cells, across six and five cell lines (Hibberts et al. 1998). The receptors bound steroids the same way in both.
The enzyme that makes DHT overlaps in the same way. DHT was recovered from cultured beard papilla cells given testosterone, but not from non-balding scalp cells (Thornton et al. 1993). Type 2 5-alpha-reductase messenger RNA was found in beard papilla cells and not in occipital scalp cells (Ando et al. 1999). And Inui and colleagues note that the same enzyme is expressed mainly in the mesenchymal cells of both beard and balding scalp follicles.
Since every cell line in Inui's experiment had the same extra androgen receptor, the authors concluded that the opposite responses "could not be attributed to the AR expression level". They pointed instead to differences in what happens after androgen binds the receptor (Inui et al. 2002).
Our reading of these studies: receptor and enzyme levels set how strongly a follicle responds to androgen. The follicle's own pattern of gene expression sets whether that response is growth or shrinkage. Finasteride and dutasteride act on the first part. They lower the DHT available to every follicle at once, and they don't change which follicles grow in response to androgen and which shrink. RU58841, an unapproved topical androgen receptor blocker, acts at the receptor itself.
What does donor dominance show about DHT?
It indicates that the response to DHT is a property of each follicle. In Orentreich's 1959 series of 52 men with male pattern baldness, transplanted follicles kept the behavior of the site they came from. Orentreich, who named the principle, put it this way: "'Hair to hair' grew hair; 'hair to bald' grew hair; 'bald to bald' remained bald; and 'bald to hair' remained bald" (Orentreich 1959). That's why grafts from the back of the scalp keep growing in a balding area.
Beard follicles can serve as scalp donors too. In one surgeon's series of 122 body hair transplant patients, beard hair was a donor source in 113 (Umar 2016). The paper notes that body hair "generally retains its characteristics when transplanted to recipient head sites". Graft take was around 75 to 80%, against about 95% for scalp donor hair. Donor dominance has limits, though, and they are part of why hair transplants are not a cure.
Does finasteride or dutasteride affect beard growth?
They don't appear to thin an established beard in most men, based on one retrospective study and the body hair data from finasteride's original trials.
The worry comes from men born with 5-alpha-reductase type 2 deficiency, who have absent or decreased facial hair (Imperato-McGinley and Zhu 2002). But those men lack the enzyme from before birth and through puberty. A man starting a drug as an adult has a beard that is largely formed. Still, beard weight rises sharply during puberty and keeps rising until the mid-thirties (Randall 2007), so the evidence below applies to an established beard.
A clinic in Madrid reviewed photographs of 453 men aged 16 to 35 with an established beard, defined as one developed similarly to the patient's father's (Moreno-Arrones et al. 2024). They had taken finasteride 1 mg (100 men) or dutasteride 0.5 mg (353 men) daily for at least 12 months.
Overall, 96.9% showed no change in beard thickness, 1.1% a decrease and 1.9% an increase. On finasteride, 94 of 100 men showed no change, 3 worsened and 3 improved. On dutasteride, 345 of 353 showed no change and 2 (0.6%) worsened.
Two limits. Beard thickness was judged from photographs without trichoscopic measurement, so a small change in density could be missed. And only men still taking the drug after at least 12 months were included, so men who stopped earlier because of beard changes would not appear.
In finasteride's two one-year pivotal trials of 1,553 men, the investigators wrote that finasteride "might be expected to decrease body hair, but no such effect was observed based on the patient body hair assessment" (Kaufman et al. 1998). Increased body hair growth was reported by 0.9% of men on finasteride and 0.9% on placebo. That assessment was patient-reported and did not measure the beard on its own. We found no randomized trial of dutasteride that measured beard growth.
Two observations are consistent with an adult beard persisting on these drugs. Randall notes that men castrated after puberty do not return to prepubertal levels of beard growth, which suggests some androgen-driven changes do not need androgens to be maintained (Randall 2007). And Moreno-Arrones and colleagues add that in transgender women, beard growth is "extremely resistant to estrogen and antiandrogen" treatment.
If you're weighing finasteride's long-term safety more broadly, see does finasteride shorten lifespan.
Does minoxidil grow beard hair?
Topical minoxidil raised beard hair in two small placebo-controlled trials, both from Thailand. It is FDA approved for scalp hair loss, and applying it to the face is off-label.
In the first, 48 men aged 20 to 60 were randomized to 3% minoxidil lotion or placebo on the chin and jawline, twice daily for 16 weeks (Ingprasert et al. 2016). Hair count at a marked point on the chin rose by an average of 5.0 on minoxidil against 0.35 on placebo (P < 0.001). The letter does not state the counting area. Hair diameter did not change significantly.
The second trial was covered in the news in November 2026. It randomized 69 transgender men on stable testosterone therapy to 3% topical minoxidil (34 men) or vehicle placebo (35 men), twice daily for 12 weeks, and measured facial hair by videodermoscopy (Wattanawinitchai et al. 2026). Against placebo:
- Beard density rose by 11.16 hairs/cm², against 0.08 (p = 0.01).
- Mustache density rose by 18.45 hairs/cm², against 1.74 (p = 0.003).
- Beard hair diameter rose by 5.37 µm, against a fall of 0.33 µm.
Adverse events were minimal and comparable between groups. ScienceAlert put the gains at about 17% for mustache density and 15% for beard density from baseline (Cassella 2026). We could not open the full text to check those baselines, so the hairs/cm² changes from the abstract are the figures we verified.
Every participant was a transgender man on testosterone, so the results may not carry over to cisgender men. ScienceAlert reports that the authors suggest ongoing testosterone may act together with minoxidil.
What is not known about the androgen paradox
The mechanism rests mostly on cultured dermal papilla cells from a handful of donors. IGF-1, TGF-beta1, DKK-1 and IL-6 are outputs of the beard and balding responses. None of these studies identifies the genes that set a follicle's direction in the first place, or when during development that setting is made.
The beard evidence for finasteride and dutasteride is one retrospective photographic study of men who stayed on treatment, plus a self-reported body hair assessment. A small effect on beard density could exist without either detecting it. The minoxidil beard data are two short trials from Thailand with 117 randomized participants in total. Neither reports what happens after treatment stops.
Frequently asked questions
Does finasteride make your beard thinner?
Finasteride does not appear to thin an established beard in most men. In a retrospective photo study, 94 of 100 men taking finasteride 1 mg daily for at least a year showed no change in beard thickness, 3 thinned and 3 thickened. Only men still taking it at 12 months were included, and photographs can miss small changes.
Does dutasteride affect beard growth?
The only direct data we found come from a Madrid study of 353 men who took dutasteride 0.5 mg daily for at least a year. On photographs, 97.7% showed no change in beard thickness, 1.7% improved and 0.6% thinned. Only men still on treatment at a year were included. Dutasteride is off-label for hair loss in the US.
Why can a bald man still grow a full beard?
Beard follicles and balding scalp follicles respond to DHT in opposite directions. In cell culture, androgen makes beard dermal papilla cells release growth signals such as IGF-1, and makes balding scalp papilla cells release inhibitory signals such as TGF-beta1 and DKK-1. So the same hormone in the blood can enlarge the beard while susceptible scalp follicles shrink.
Does minoxidil work for beard growth?
Topical minoxidil is not FDA approved for beard growth. In two small placebo-controlled trials from Thailand, 3% lotion raised beard hair counts in 48 men over 16 weeks. In 69 transgender men on testosterone, it raised beard density by 11.16 hairs/cm² against 0.08 on placebo over 12 weeks. Neither trial reports results after stopping.
Can beard hair be transplanted to the scalp?
Beard hair can be used as donor hair for the scalp when scalp donor hair is limited. In one surgeon's series of 122 body hair transplant patients, beard hair was a donor source in 113, and the paper notes that body hair generally keeps its characteristics on the scalp. Graft take is lower than with scalp donor hair, around 75 to 80%.
Do men with low DHT go bald?
Men born with 5-alpha-reductase type 2 deficiency, who make less DHT, have absent or decreased facial and body hair, and balding has not been reported in them. People with complete androgen insensitivity, who lack a working androgen receptor, do not develop a normal beard, and male pattern baldness has not been reported in them either.
References
- Randall VA. Hormonal regulation of hair follicles exhibits a biological paradox. Semin Cell Dev Biol. 2007;18(2):274-285. DOI: 10.1016/j.semcdb.2007.02.004Cited in Why does DHT grow beard hair but cause baldness? (3) · What do beard and balding papilla cells do differently? · Does finasteride or dutasteride affect beard growth? (2)
- Hibberts NA, Howell AE, Randall VA. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol. 1998;156(1):59-65. DOI: 10.1677/joe.0.1560059Cited in Why does DHT grow beard hair but cause baldness? · Do beard follicles have more androgen receptors than scalp follicles?
- Imperato-McGinley J, Zhu YS. Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. Mol Cell Endocrinol. 2002;198(1-2):51-59. DOI: 10.1016/s0303-7207(02)00368-4Cited in Why does DHT grow beard hair but cause baldness? · Does finasteride or dutasteride affect beard growth?
- Hamada K, Randall VA. Inhibitory autocrine factors produced by the mesenchyme-derived hair follicle dermal papilla may be a key to male pattern baldness. Br J Dermatol. 2006;154(4):609-618. DOI: 10.1111/j.1365-2133.2006.07144.xCited in Why does DHT grow beard hair but cause baldness? · What do beard and balding papilla cells do differently?
- Inui S, Fukuzato Y, Nakajima T, Yoshikawa K, Itami S. Androgen-inducible TGF-beta1 from balding dermal papilla cells inhibits epithelial cell growth: a clue to understand paradoxical effects of androgen on human hair growth. FASEB J. 2002;16(14):1967-1969. DOI: 10.1096/fj.02-0043fjeCited in Introduction · Why does DHT grow beard hair but cause baldness? · What do beard and balding papilla cells do differently? · Do beard follicles have more androgen receptors than scalp follicles?
- Itami S, Kurata S, Takayasu S. Androgen induction of follicular epithelial cell growth is mediated via insulin-like growth factor-I from dermal papilla cells. Biochem Biophys Res Commun. 1995;212(3):988-994. DOI: 10.1006/bbrc.1995.2067Cited in What do beard and balding papilla cells do differently?
- Thornton MJ, Hamada K, Messenger AG, Randall VA. Androgen-dependent beard dermal papilla cells secrete autocrine growth factor(s) in response to testosterone unlike scalp cells. J Invest Dermatol. 1998;111(5):727-732. DOI: 10.1046/j.1523-1747.1998.00396.xCited in What do beard and balding papilla cells do differently?
- Kwack MH, Sung YK, Chung EJ, et al. Dihydrotestosterone-inducible dickkopf 1 from balding dermal papilla cells causes apoptosis in follicular keratinocytes. J Invest Dermatol. 2008;128(2):262-269. DOI: 10.1038/sj.jid.5700999Cited in What do beard and balding papilla cells do differently?
- Kwack MH, Ahn JS, Kim MK, Kim JC, Sung YK. Dihydrotestosterone-inducible IL-6 inhibits elongation of human hair shafts by suppressing matrix cell proliferation and promotes regression of hair follicles in mice. J Invest Dermatol. 2012;132(1):43-49. DOI: 10.1038/jid.2011.274Cited in What do beard and balding papilla cells do differently?
- Rutberg SE, Kolpak ML, Gourley JA, et al. Differences in expression of specific biomarkers distinguish human beard from scalp dermal papilla cells. J Invest Dermatol. 2006;126(12):2583-2595. DOI: 10.1038/sj.jid.5700454Cited in What do beard and balding papilla cells do differently?
- Randall VA, Thornton MJ, Messenger AG. Cultured dermal papilla cells from androgen-dependent human hair follicles (e.g. beard) contain more androgen receptors than those from non-balding areas of scalp. J Endocrinol. 1992;133(1):141-147. DOI: 10.1677/joe.0.1330141Cited in What do beard and balding papilla cells do differently? · Do beard follicles have more androgen receptors than scalp follicles?
- Ando Y, Yamaguchi Y, Hamada K, Yoshikawa K, Itami S. Expression of mRNA for androgen receptor, 5alpha-reductase and 17beta-hydroxysteroid dehydrogenase in human dermal papilla cells. Br J Dermatol. 1999;141(5):840-845. DOI: 10.1046/j.1365-2133.1999.03156.xCited in Do beard follicles have more androgen receptors than scalp follicles?
- Thornton MJ, Laing I, Hamada K, Messenger AG, Randall VA. Differences in testosterone metabolism by beard and scalp hair follicle dermal papilla cells. Clin Endocrinol (Oxf). 1993;39(6):633-639. DOI: 10.1111/j.1365-2265.1993.tb02420.xCited in Do beard follicles have more androgen receptors than scalp follicles?
- Orentreich N. Autografts in alopecias and other selected dermatological conditions. Ann N Y Acad Sci. 1959;83(3):463-479. DOI: 10.1111/j.1749-6632.1960.tb40920.xCited in What does donor dominance show about DHT?
- Umar S. Body hair transplant by follicular unit extraction: my experience with 122 patients. Aesthet Surg J. 2016;36(10):1101-1110. DOI: 10.1093/asj/sjw089Cited in What does donor dominance show about DHT?
- Moreno-Arrones OM, Saceda-Corralo D, Ortega-Quijano D, Hermosa-Gelbard A, Vañó-Galván S. Impact of finasteride and dutasteride in beard thickness in men with androgenetic alopecia: a 453-patient retrospective trial. Actas Dermosifiliogr. 2024;115(10):1015-1016. DOI: 10.1016/j.ad.2023.05.046Cited in Introduction · Does finasteride or dutasteride affect beard growth?
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4 Pt 1):578-589. DOI: 10.1016/s0190-9622(98)70007-6Cited in Does finasteride or dutasteride affect beard growth?
- Ingprasert S, Tanglertsampan C, Tangphianphan N, Reanmanee C. Efficacy and safety of minoxidil 3% lotion for beard enhancement: a randomized, double-masked, placebo-controlled study. J Dermatol. 2016;43(8):968-969. DOI: 10.1111/1346-8138.13312Cited in Does minoxidil grow beard hair?
- Wattanawinitchai K, Pomsoong C, Ratanapokasatit Y, Suchonwanit P. Efficacy and safety of topical 3% minoxidil for facial hair enhancement in transmen: a randomized, double-blind, placebo-controlled trial. J Dermatolog Treat. 2026;37(1):2638637. DOI: 10.1080/09546634.2026.2638637Cited in Does minoxidil grow beard hair?
- Cassella C. Common topical drug can help grow a fuller beard in just 8 weeks. ScienceAlert. 2026 Nov 10. https://www.sciencealert.com/scientists-find-a-way-to-grow-a-thicker-and-fuller-mustache-in-just-8-weeksCited in Does minoxidil grow beard hair?
This article is for educational purposes only and is not medical advice. Oral finasteride 1 mg is FDA approved for male pattern hair loss and topical minoxidil is FDA approved for scalp hair loss; dutasteride is used off-label for hair loss in the United States, and applying minoxidil to the face or beard is off-label. Prescription treatments are decisions to make with a qualified clinician who knows your history. Compounded medications, including those Anagen prescribes, are not FDA approved. Most of the mechanism research described here was done in cultured cells, and none of it describes an Anagen product.


